Talis Biomedical Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
0.43
|
|
Average Rating
|
1.50
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.78
|
-0.98
|
-0.20
|
-25.64%
|
|
2022-06-30
|
-0.80
|
-1.01
|
-0.21
|
-26.25%
|
|
2022-03-31
|
-1.18
|
-1.25
|
-0.07
|
-5.93%
|
|
2021-12-31
|
-1.28
|
-1.26
|
0.02
|
1.56%
|
|
2021-09-30
|
-1.40
|
-1.49
|
-0.09
|
-6.43%
|
|
2021-06-30
|
-0.91
|
-2.51
|
-1.60
|
-175.82%
|
|
2021-03-31
|
-0.75
|
-4.61
|
-3.86
|
-514.67%
|
|
2020-12-31
|
-0.78
|
-20.84
|
-20.06
|
-2571.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.24
|
|
2021-12-31
|
-9.87
|
|
2020-12-31
|
-21.60
|